You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
植耀輝: 「股債雙殺」道指急跌 港股考驗19,500點支持
耀才證券研究部總監植耀輝稱,美股隔晚(22日)急挫,Jackson Hole全球央行年會即將登場,投資者擔心聯儲局主席鮑威爾或釋出鷹派言論,美債息及美匯急升,美股亦大幅下跌,當中科技股跌勢頗急,納指便大跌2.6%,至於道指及標普500指數亦分別下跌近2%及2.1%。 至於港股昨日則輾轉回落,早段一度急跌至19,564點後反彈,在A股造好支持下一度倒升,最高曾升至19,825點,不過隨著美期下跌,權重股如匯控(00005.HK)等亦拖累港股表現,最終恆指下跌116點,收報19,656點,大市成交維持在830億元水平。成份股中表現最佳為宏橋(01378.HK),上升4.3%,內房股亦見反彈,碧服(06098.HK)及碧桂園(02007.HK)便分別反彈3.9%及3.2%。內地體育用品股亦有好表現,李寧(02331.HK)及安踏(02020.HK)分別上升2.4%及3.5%。個別業績股表現則較失色,新奧能源(02688.HK)大跌14.3%,小米-W(01810.HK)亦跌近3.3%。 至於四隻準恆指成份股表現呈個別發展,當中以翰森製藥(03692.HK)表現最佳,累升3.2%,中國神華(01088.HK)亦升2.1%,百度-SW(09888.HK)則微升0.9%,不過周大福(01929.HK)則跟隨大市回落,收報16.26元,微跌0.6%。 由於大市整體氣氛仍不理想,加上投資者仍等待Jackson Hole年會各央行行長對經濟前景及息口去向之情況,故觀望氣氛將持續,預期恆指暫會於19,500至20,000點水平上落。 (筆者為證監會持牌人,並未持有相關股份) ************ 中國平安、中生製藥、安踏及恆地今公布業績 耀才研究部稱,美股連續兩日下跌,隔晚(22日)三大指數再跌約1.9%至2.6%,明星科技股普遍下跌,Netflix(NFLX.US)大跌6%。美國NABE調查顯示,72%的受訪經濟學家認為2023年中開始美國將出現衰退,市場同時亦擔心聯儲局將持續鷹派的加息步伐,美10年期國債息率再度升穿3厘,美匯指數亦曾經突破109的水平,再創自2002年的新高,拖累股市的氣氛。港股方面,中概股隔晚升1.2%,新能源車有望反彈勢頭,另一方面亦關注業績股,中國平安(02318.HK)、中生製藥(01177.HK)、安踏(02020.HK)及恆地(00012.HK)今日(23日)公布業績。 至於技術走勢方面,恆指一直受壓於10天線,將持續下試月內低位19,500點,投資者小心MACD接近出現熊信號,屆時沽壓亦會再度加深。 (筆者為證監會持牌人)~
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account